Unigene Laboratories Inc.
81 Fulton Street
Boonton,
NJ 07005
United States - Map
Phone: 973-265-1100
Fax: 973-335-0972
Web Site: http://www.unigene.com
| Unigene Laboratories, Inc., a biopharmaceutical company, engages in the research, production, and delivery of peptides for medical use primarily in the United States. The company focuses on the development of calcitonin and other peptide products for the treatment of osteoporosis and other indications, including nasal and oral calcitonin, and oral parathyroid hormone (PTH). It offers Fortical, a nasal calcitonin product for the treatment of postmenopausal osteoporosis. Unigene Laboratories has licensing agreements with GlaxoSmithKline to develop an oral formulation of an analog of PTH; Upsher-Smith Laboratories, Inc. to market Fortical; Novartis Pharma AG to manufacture calcitonin; and Shijiazhuang Pharmaceutical Group for research, development, and manufacture of recombinant salmon calcitonin and non-oral PTH. The company was founded in 1980 and is based in Boonton, New Jersey. |
|
| Key Statistics |
| |
| | Pay | Exercised | Mr. Jay Levy , 86
Co-Founder, Chairman, Treasurer and Assistant Sec. |
N/A
| N/A | Dr. Warren P. Levy Ph.D., 58
Co-Founder, Chief Exec. Officer, Pres |
N/A
| N/A | Dr. Ronald S. Levy , 61
Co-Founder, Exec. VP, Sec. |
N/A
| N/A | Mr. William J. Steinhauer CPA, 55
Principal Financial Officer, Principal Accounting Officer and VP of Fin. |
N/A
| N/A | Dr. James P. Gilligan , 58
VP of Product Devel. |
N/A
| N/A |
|
|
|
Dollar amounts are as of
31-Dec-08
and compensation values are for the last fiscal
year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of
options exercised during the fiscal year.
| |
|
0.31% Nasdaq 
0.05%
Profile
